We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,457.00
Bid: 4,473.00
Ask: 4,475.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.045%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,457.00
RKT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

5 Apr 2024 10:00

RNS Number : 3870J
Reckitt Benckiser Group PLC
05 April 2024
 

5 April 2024

 

RECKITT BENCKISER GROUP PLC

("Reckitt" or the "Company")

 

2023 Annual Report and Financial Statements and Notice of 2024 Annual General Meeting

 

Reckitt confirms that the following documents have been published today and are available on its website, www.reckitt.com:

 

· Annual Report and Financial Statements for the year ended 31 December 2023 ("2023 Annual Report")

· Notice of the 2024 Annual General Meeting ("AGM") to be held on 2 May 2024 ("2024 AGM Notice")

 

In compliance with LR 9.6.1, the following documents have been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

· 2023 Annual Report

· 2024 AGM Notice

· Form of Proxy for the 2024 AGM

 

In conformity with DTR 6.3.5(1A) the regulated information required under DTR 6.3.5 is available in unedited full text within the 2023 Annual Report as uploaded and available on the National Storage Mechanism and on the Company's website as noted above.

 

The Company's AGM will be held at 2pm on Thursday 2 May 2024 at the London Heathrow Marriott Hotel, Bath Road, Hayes UB3 5AN. The 2023 Annual Report together with the 2024 AGM Notice and Form of Proxy will be mailed or otherwise made available to shareholders in due course.

 

For further Information: Catheryn O'Rourke

Company Secretary

Tel +44 (0) 1753 217 800

 

Richard Joyce

Head of Investor Relations

Tel +44 (0) 7408 812 062

 

  

About Reckitt:

Reckitt* exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Every day, around 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSSSSFLLELSELL
Date   Source Headline
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:01 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:01 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNS1st Quarter Results
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202410:00 amRNSAnnual Financial Report
4th Apr 202410:15 amRNSShare Buyback Programme - Third Tranche
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:21 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:00 pmRNSDirector Declaration
27th Mar 202411:30 amRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSShare Buyback Programme - Third Tranche
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20244:00 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:01 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSReplacement - Transaction in Own Shares
15th Mar 20243:44 pmRNSStatement re NEC Litigation
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Mar 202411:00 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.